Interestingly, among the CXCR4+ cancer types there are solid tumors of high prevalence and very poor response to current treatments such as pancreatic cancer, gastric carcinoma and non-small cell lung cancer [47, 60]. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.